http://www.aaa3.net/physician-rating-scale-gait/
Committee for Medicinal Products for Human Use (CHMP) Opinion on European regulatory issues for submitting Merck … WHITEHOUSE STATION, NJ —- Merck announced that the Committee for Medicinal Products for Human Use has adopted a positive opinion on the pending application for marketing authorization for SYCREST ® sublingual tablets.
